Amylyx Pharmaceuticals, Inc. ( AMLX) - Key Metrics
AMLX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.39 | -$0.28 | -$0.28 |
| 2026Q1 | $0 | -$0.37 | -$0.33 | -$0.33 |
| 2025Q4 | $0 | -$0.35 | -$0.30 | -$0.30 |
| 2025Q3 | $0 | -$0.37 | -$0.33 | -$0.33 |
| 2025Q2 | $0 | -$0.46 | -$0.28 | -$0.28 |
AMLX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -11.51 |
| 2026Q1 | 0% | -9.39 |
| 2025Q4 | 0% | -10.79 |
| 2025Q3 | 0% | -9.18 |
| 2025Q2 | 0% | -3.48 |
AMLX
Price: $21.63
52 week price:
Earnings Per Share: -1.47 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 390250
Market Capitalization: 2.6 billion